{{Drugbox
| IUPAC_name = N-(adamantan-1-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
| image = FUB-APINACA.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule II
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = 
| legal_NZ = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 118796517
| ChemSpiderID      = 30922497
| UNII = OF9Q7PH4UD
| smiles            = O=C(NC1(C[C@H]2C3)C[C@H]3C[C@H](C2)C1)C4=NN(CC5=CC=C(F)C=C5)C6=C4C=CC=C6
| StdInChI          = 1S/C25H26FN3O/c26-20-7-5-16(6-8-20)15-29-22-4-2-1-3-21(22)23(28-29)24(30)27-25-12-17-9-18(13-25)11-19(10-17)14-25/h1-8,17-19H,9-15H2,(H,27,30)/t17-,18+,19-,25?
| StdInChIKey       = MWBHSNBPUSKVDD-LPSAYFBNSA-N

<!--Chemical data-->
| C=25 | H=26 | F=1 | N=3 | O=1
| molecular_weight = 403.5 g/mol
}}

'''FUB-APINACA''' (also known as '''FUB-AKB48''') is an [[indazole]]-based [[synthetic cannabinoid]] that is presumed to be a potent [[agonist]] of the [[CB1 receptor|CB<sub>1</sub> receptor]] and has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/15937 | title=FUB-AKB48 | publisher=Cayman Chemical | accessdate=23 July 2015}}</ref> It is an analogue of [[APINACA]] and [[5F-APINACA]] where the pentyl chain has been replaced with fluorobenzyl.

==Pharmacology==
FUB-AKB-48 acts as a [[full agonist]] with a [[Affinity (pharmacology)#Protein-ligand binding|binding affinity]] of 1.06nM at [[Cannabinoid receptor type 1|CB<sub>1</sub>]] and 0.174nM at [[Cannabinoid receptor type 2|CB<sub>2</sub>]] [[cannabinoid]] receptors.<ref>{{cite journal|first1=Cornelius|last1=Hess|first2=ClaraT.|last2=Schoeder|first3=Thanigaimalai|last3=Pillaiyar|first4=Burkhard|last4=Madea|title=Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice|journal=Forensic Toxicology|date=1 July 2016|issn=1860-8965|pages=329–343|volume=34|issue=2|doi=10.1007/s11419-016-0320-2|first5=ChristaE.|last5=Müller|pmid=27429655|pmc=4929166}}</ref>

== Legal status ==

Sweden's public health agency suggested classifying FUB-APINACA as a hazardous substance on November 10, 2014.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider föreslås bli klassade som hälsofarlig vara | publisher=Folkhälsomyndigheten | accessdate=23 July 2015}}</ref>

It is also illegal in [[Alabama]] (listed as FUB-AKB48).<ref>[https://legiscan.com/AL/text/SB333/id/988417/Alabama-2014-SB333-Enrolled.pdf Alabama Senate Bill SB 333: Controlled Substances]</ref>

==See also==
{{div col|colwidth=30em}}
* [[5F-ADB]]
* [[5F-AMB]]
* [[AB-FUBINACA]]
* [[AB-CHFUPYCA]]
* [[AB-PINACA]]
* [[ADAMANTYL-THPINACA]]
* [[ADB-CHMINACA]]
* [[ADB-FUBINACA]]
* [[ADB-PINACA]]
* [[ADBICA]]
* [[APP-FUBINACA]]
* [[FAB-144]]
* [[MDMB-CHMINACA]]
* [[MDMB-FUBINACA]]
* [[PX-3]]
{{Div col end}}

==References==
{{reflist}}

{{Cannabinoids}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Indazoles]]
[[Category:Fluoroarenes]]
[[Category:Indazolecarboxamides]]


{{cannabinoid-stub}}